A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO DETERMINE THE EFFICACY AND SAFETY OF AAV2-HAQP1 GENE THERAPY IN PARTICIPANTS WITH RADIATION-INDUCED LATE XEROSTOMIA

Registry ID

MGT-AQP1-201

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

MEIRAGTX LLC

Start date

2024-01-23

Last update

2023-09-29

Conditions

• XEROSTOMIA

Related clinical trials

• LONG-TERM FOLLOW-UP OF AAV2-HAQP1 GENE THERAPY IN PARTICIPANTS WITH RADIATION-INDUCED LATE XEROSTOMIA

View on source registry